XML 42 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
Selected Quarterly Financial Information
12 Months Ended
Dec. 31, 2015
Selected Quarterly Financial Information [Abstract]  
Selected Quarterly Financial Information (Unaudited)

SELECTED QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

First

 

Second

 

Third

 

Fourth

 

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

REVENUE:

 

 

 

 

 

 

 

 

 

 

 

 

2015

$

33,831 

 

$

35,526 

 

$

36,703 

 

$

39,838 

 

2014

 

35,731 

 

 

34,690 

 

 

37,069 

 

 

37,151 

 

2013

 

35,536 

 

 

33,520 

 

 

36,250 

 

 

35,457 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GROSS MARGIN:

 

 

 

 

 

 

 

 

 

 

 

 

2015

$

19,667 

 

$

21,554 

 

$

22,982 

 

$

26,516 

 

2014

 

22,473 

 

 

22,384 

 

 

23,799 

 

 

22,635 

 

2013

 

23,276 

 

 

21,479 

 

 

23,349 

 

 

22,282 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET (LOSS) INCOME:

 

 

 

 

 

 

 

 

 

 

 

 

2015

$

(274)

 

$

(502)

 

$

2,145 

 

$

2,636 

 

2014

 

1,059 

 

 

2,161 

 

 

2,326 

 

 

1,776 

 

2013

 

2,192 

 

 

1,785 

 

 

3,169 

 

 

9,026 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

(LOSS) INCOME PER COMMON SHARE—DILUTED:

 

 

 

 

 

 

 

 

 

 

 

 

2015

$

(0.01)

 

$

(0.02)

 

$

0.07 

 

$

0.09 

 

2014

 

0.04 

 

 

0.08 

 

 

0.08 

 

 

0.06 

 

2013

 

0.08 

 

 

0.06 

 

 

0.11 

 

 

0.31 

*

 

 

*The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc.’s acquisition of the outstanding common shares of Medafor, Inc. and the unfavorable effect of a $3.2 million other than temporary investment impairment as a result of the impairment and write-down of the Company’s investment in ValveXchange preferred stock.